GE HealthCare beats Q2 estimates with $1.13 EPS on imaging demand

GE HealthCare Technologies Inc. posted second-quarter earnings of $1.13 a share, surpassing the $1.04 consensus estimate by 8.7%, as strong demand for medical imaging equipment and tariff refunds lifted the medical device maker's results.

The Chicago-based company reported earnings per share of $1.13 for the quarter ended June 30, compared with $1.06 in the same period a year ago, a year-over-year increase of 6.6%. Revenue also exceeded Wall Street expectations, though the company did not disclose the exact figure in its preliminary release. The Zacks Consensus Estimate had called for $1.04 per share.

GE HealthCare, spun off from General Electric Co. in January 2023, is one of the world's largest suppliers of medical imaging equipment, including MRI, CT, and ultrasound systems. Its product portfolio spans the full diagnostic imaging spectrum, from high-field MRI scanners used for neurological imaging to portable ultrasound devices for point-of-care applications. The company's performance is closely tied to hospital capital spending, which has remained resilient despite broader economic uncertainty.

Rival Siemens Healthineers and Koninklijke Philips NV also reported steady demand in their most recent quarters, suggesting the imaging market is benefiting from a post-pandemic catch-up in equipment purchases. Many hospitals delayed capital expenditures during the pandemic, creating a replacement backlog for MRI and CT systems that typically follow a five-to-seven-year upgrade cycle. The global medical imaging market is estimated at more than $40 billion annually, with GE HealthCare, Siemens Healthineers, and Philips holding the majority share.

The earnings beat reflects stronger-than-expected operational performance for GE HealthCare, driven by sustained hospital investment in diagnostic imaging and the benefit of tariff refunds. The company's ability to exceed profit estimates suggests its product portfolio and cost discipline are providing a competitive edge against peers in the medical device sector. With hospitals continuing to prioritize imaging equipment upgrades and the company benefiting from tariff-related adjustments, GE HealthCare appears well-positioned to maintain its earnings momentum through the second half of the fiscal year.

This article is for informational purposes only and does not constitute investment advice.